Conference Coverage

Structural racism tied to psychosis risk in Black people


 

Call to action

Commenting on the findings in an interview, Ned H. Kalin, MD, editor of The American Journal of Psychiatry and professor and chair of the department of psychiatry, University of Wisconsin, Madison, said the study was well done and serves as a “call to action” to address the impact of structural racism on mental health issues and psychiatric diseases.

The article highlights the need for “collecting better data” on structural racism, said Dr. Kalin. “We know it’s a big issue, but we can’t even quantitate it, so we need some fundamental measures to use as a benchmark as we move forward, as we try to make change.”

He noted that racism “is so embedded in one’s experience and in our society that we sort of don’t even think about it as a trauma.”

In psychiatry, for example, trauma is often thought of as a loss or a traumatic event. “We don’t typically think of trauma as an experience that pervades one’s entire life,” but that needs to change, he said. “At the individual level and in the doctor’s office, being sensitive to and aware of these issues is absolutely critical.”

Dr. Anglin and Dr. Kalin have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Steroid-induced psychiatric symptoms: What you need to know
MDedge Psychiatry
Contradictions abound in ‘The End of Mental Illness’
MDedge Psychiatry
Antipsychotics protective against COVID-19?
MDedge Psychiatry
Cortical surface changes linked to sensorimotor abnormalities in schizophrenia
MDedge Psychiatry
10 devastating consequences of psychotic relapses
MDedge Psychiatry
Are psychiatric disorders a ‘canary in a coal mine’ for Alzheimer’s disease?
MDedge Psychiatry
Potential first-in-class schizophrenia drug cuts negative symptoms
MDedge Psychiatry
Nonpharma approach a potential ‘game changer’ in schizophrenia?
MDedge Psychiatry
The cloudy role of cannabis as a neuropsychiatric treatment
MDedge Psychiatry
Novel drug offers rapid relief from agitation in serious mental illness
MDedge Psychiatry